rs267608324

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS2

The NM_004992.4(MECP2):​c.-15C>T variant causes a 5 prime UTR change. The variant allele was found at a frequency of 0.0000275 in 1,199,391 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 10 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0000094 ( 0 hom., 0 hem., cov: 20)
Exomes 𝑓: 0.000029 ( 0 hom. 10 hem. )

Consequence

MECP2
NM_004992.4 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter U:1B:1

Conservation

PhyloP100: 4.21

Publications

0 publications found
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]
MECP2 Gene-Disease associations (from GenCC):
  • chromosome Xq28 duplication syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • Rett syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, G2P
  • severe neonatal-onset encephalopathy with microcephaly
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • syndromic X-linked intellectual disability Lubs type
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • atypical Rett syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked intellectual disability-psychosis-macroorchidism syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • systemic lupus erythematosus
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant X-154092224-G-A is Benign according to our data. Variant chrX-154092224-G-A is described in ClinVar as Benign. ClinVar VariationId is 143299.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAdExome4 at 32 XL,Unknown,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MECP2NM_004992.4 linkc.-15C>T 5_prime_UTR_variant Exon 2 of 4 ENST00000303391.11 NP_004983.1
MECP2NM_001110792.2 linkc.62+5380C>T intron_variant Intron 1 of 2 ENST00000453960.7 NP_001104262.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MECP2ENST00000303391.11 linkc.-15C>T 5_prime_UTR_variant Exon 2 of 4 1 NM_004992.4 ENSP00000301948.6
MECP2ENST00000453960.7 linkc.62+5380C>T intron_variant Intron 1 of 2 1 NM_001110792.2 ENSP00000395535.2

Frequencies

GnomAD3 genomes
AF:
0.00000942
AC:
1
AN:
106155
Hom.:
0
Cov.:
20
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000193
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000164
AC:
3
AN:
183111
AF XY:
0.0000296
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000367
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000293
AC:
32
AN:
1093236
Hom.:
0
Cov.:
30
AF XY:
0.0000279
AC XY:
10
AN XY:
358726
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26300
American (AMR)
AF:
0.00
AC:
0
AN:
35158
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19317
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30136
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53999
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40347
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4124
European-Non Finnish (NFE)
AF:
0.0000370
AC:
31
AN:
837945
Other (OTH)
AF:
0.0000218
AC:
1
AN:
45910
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000942
AC:
1
AN:
106155
Hom.:
0
Cov.:
20
AF XY:
0.00
AC XY:
0
AN XY:
28915
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
28931
American (AMR)
AF:
0.00
AC:
0
AN:
9692
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2589
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3419
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2364
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5028
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
229
European-Non Finnish (NFE)
AF:
0.0000193
AC:
1
AN:
51841
Other (OTH)
AF:
0.00
AC:
0
AN:
1391
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.275
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.000102
Hom.:
1

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Rett syndrome Uncertain:1Benign:1
Feb 18, 2024
Centre for Population Genomics, CPG
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is between 0.008% and 0.03% (BS1). The variant is observed in at least 2 individuals with no features of Rett Syndrome (BS2).PMID 10814719 , 10 hemizygous in gnomAD V4. Variant is found in an individual with an alternate molecular basis of disease (BP5). PMID: 10814719 -

Apr 10, 2002
RettBASE
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:curation

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.36
CADD
Uncertain
23
DANN
Benign
0.93
PhyloP100
4.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=299/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs267608324; hg19: chrX-153357682; API